Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results

Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results

Melanoma is the most lethal form of skin cancer and its incidence is growing worldwide. In the last ten years, the therapeutic scenario of this disease has been revolutionized by the introduction of targeted therapies and immune-checkpoint inhibitors. However, in patients with many lesions and bulky...

Full description

Bibliographic Details
Main Authors: Teresa Troiani, Stefania Napolitano, Gabriella Brancaccio, Valentina Belli, Annarita Nappi, Caterina Miro, Domenico Salvatore, Monica Dentice, Michele Caraglia, Renato Franco, Emilio Francesco Giunta, Vincenzo De Falco, Davide Ciardiello, Fortunato Ciardiello, Giuseppe Argenziano
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Personalized Medicine
Subjects:
melanoma
imiquimod
SMO
Hedgehog pathway
Online Access:https://www.mdpi.com/2075-4426/11/3/206

Internet

https://www.mdpi.com/2075-4426/11/3/206

Similar Items